Entries by

4. Euripid Stakeholder Dialogue Platform

We are happy to announce that the 4th Stakeholder Dialogue Platform took place on 11 May 2021 with again very interesting inputs form DG SANTE, EFPIA, Medicines for Europe and OECD. Also, the Euripid Executive Committee presented their Ideas regarding access to medicinal products for European citizens. The minutes and the presentations can be obtain […]

Survey among EURIPID members

A recent survey among Euripid members confirmed their interest in sharing not only concrete price information but also information on the application of Managed Entry Agreements for individual products. Currently, 13 countries share information on MEAs for all or selected products. Another priority that was recently confirmed by members is the provision of volume information. […]

Pharmaceutical Strategy for Europe

Adopted on 25 November 2020, the Pharmaceutical Strategy for Europe aims at creating a future proof regulatory framework and at supporting industry in promoting research and technologies that actually reach patients in order to fulfil their therapeutic needs while addressing market failures. Read more

WHO Fair Pricing Forum 2021

The 3rd Fair Pricing Forum took place online from 13-22 April 2021 and focused again on improving access to medicines and health products through fair pricing, following the inaugural forum held in the Netherlands in 2017 (10–11 May) and the second forum in South Africa in 2019 (11-13 April). WHO invited the Euripid Collaboration to present […]